Condition: COPD
Interventions: Drug: RPL554 Suspension; Drug: Placebo; Drug: Tiotropium/olodaterol (Respimat)
Sponsor: Verona Pharma plc
Recruiting
ClinicalTrials.gov: Hematology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
Bronchodilator Effect of RPL554 Administered in Addition to Tiotropium/Olodaterol in Patients With COPD
September 19, 2018 / by ClinicalTrials.gov / in Hematology
Comments